Streetbeat News

Earnings

SNPO

Snap One Holdings (NASDAQ:SNPO) reported Q4 earnings with an EPS of $0.15, beating estimates by 36.0% but with a revenue decrease of $3.85 million from the previous year. The company's past earnings performance shows mixed results with a miss in the last quarter leading to a 3.0% share price drop.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 9:25 pm

ELUT

Elutia (NASDAQ:ELUT) reported Q4 earnings with an EPS of $-0.66, missing estimates by -136.0% and a revenue decrease of $6.79 million from the previous year. Despite beating EPS estimates last quarter, this marks a significant downturn.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 9:25 pm

ONCT

Oncternal Therapeutics (NASDAQ:ONCT) reported Q4 earnings with an EPS of $-3.11, missing estimates by -1.0% against an expected $-3.07. Revenue increased by $126 thousand year-over-year. The company's past earnings performance shows a pattern of missing EPS estimates, which previously led to a 3.0% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 9:25 pm

GPS

Gap Inc forecasts its fiscal year 2024 net sales to remain approximately unchanged on a 52-week basis, while anticipating a gross margin expansion of at least 50 basis points.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:25 pm

SNPO

Snap One Holdings (SNPO) reported Q4 2023 adjusted EPS of $0.150, surpassing the $0.110 estimate, but its sales of $264.388M fell short of the $266.083M forecast, marking a 1.44% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:25 pm

IOT

Samsara (NYSE:IOT) reported its Q1 2025 earnings, posting an adjusted EPS of $0.040, which exceeded the analyst consensus estimate of $(0.010) by 500 percent.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:23 pm

ONCT

Oncternal Therapeutics reported Q4 2023 GAAP EPS of $(3.110), missing the $(3.070) estimate, but their sales of $297K beat the $137.5K estimate, showing significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:23 pm

ELUT

Elutia reported Q4 2023 GAAP EPS of $(0.660), missing the $(0.280) estimate, with sales of $5.875M also missing the $6.550M estimate. This represents a 53.61% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:23 pm

ALXO

ALX Oncology Holdings (NASDAQ:ALXO) reported Q4 earnings with losses of $(0.93) per share, missing the consensus estimate of $(0.86) by 8.14%. This represents a 55% increase in losses compared to $(0.60) per share from the same period last year.

Portfolio Pulse from Happy Mohamed

March 07, 2024 | 9:23 pm

ALXO

ALX Oncology Holdings (NASDAQ:ALXO) reported Q4 2023 GAAP EPS of $(0.930), missing the consensus estimate of $(0.860) by 8.14%.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:22 pm